Navigate Up
Sign In

Section of Bone Marrow Transplant

The Coleman Foundation Comprehensive Blood and Bone Marrow Transplant Clinic at Rush is nationally renowned for its innovative approaches to treating diseases such as leukemia, Hodgkin and non-Hodgkin lymphoma, multiple myeloma, severe aplastic anemiatesticular cancer, and sarcoma.

Our program is accredited by the Foundation for the Accreditation of Cellular Therapy. FACT accreditation is a voluntary process whereby transplant programs adhere to compliance with standards for the provision of quality medical and laboratory practice in hematopoietic cell transplantation.​


John J. Maciejewski, MD, PhD, is an Assistant Professor of Medicine in the Section of Bone Marrow Transplant and Cell Therapy at Rush, as well as the Clinical Program Director for Foundation for the Accreditation of Cellular Therapy (FACT). He staffs the outpatient bone marrow transplant (BMT) clinics as well as the inpatient bone marrow transplant rounds. His primary focus in stem cell transplantation has been in the fields of acute leukemia and multiple myeloma; he participates in both the Leukemia Comprehensive Care Clinic and the Multiple Myeloma Comprehensive Care Clinic. Dr. Maciejewski follows patients from diagnosis, through initial induction therapy, then throughout the stem cell transplantation process, and beyond. He also treats patients who suffer from graft-versus-host disease (GVHD), as well as patients who suffer from disease relapse after allogeneic stem cell transplantation. He is planning the inception of a BMT clinic devoted to the treatment of patients who have relapsed following allogeneic stem cell transplantation.

He is the principal investigator at Rush for several clinical trials targeting bone marrow transplant recipients and multiple myeloma patients. One of these clinical trials (BMT CTN 0702) is a study of single autologous transplant with or without consolidation therapy versus tandem autologous transplant with lenalidomide maintenance for multiple myeloma.

In addition, he has pledged to serve as a first-responder for the Midwestern United States in the Radiation Injury Treatment Network (RITN), which provides comprehensive evaluation and treatment for mass casualties with marrow toxic injuries from ionizing radiation exposure or other hazardous material.

Dr. Maciejewski holds memberships in the American Society for Blood and Marrow Transplantation, the American Society of Hematology, the American Society of Clinical Oncology, and in the Scientific Research Society, Sigma Xi. 

Sunita Nathan, MD, is the Interim Section Chief of the Section of Bone Marrow Transplant and Cell Therapy at Rush University Medical Center (RUMC) and an Assistant Professor of Medicine in the Department of Internal Medicine. She received her MD from BJ Medical College, University of Pune, India. She completed her residency in Internal Medicine as well as fellowship in Hematology and Oncology at the John H. Stroger, Jr. Hospital of Cook County (Cook County Hospital) in Chicago where she also served as Chief Resident and Chief Fellow.  During her senior year of fellowship, Dr. Nathan pursued subspecialty training in  bone marrow transplantation and hematologic malignancies, under Dr. Henry Fung at Rush University Medical Center. 

Dr. Nathan is triple-board certified in Internal Medicine, Hematology and Medical Oncology.  She holds memberships in the American Society of Hematology, the American Society of Clinical Oncology, the American Society for Blood and Marrow Transplantation and the American College of Physicians.  Dr. Nathan's main area of clinical interest is use of allogeneic stem cell transplantation in various hematologic malignancies with a focus on its use in lympho-proliferative disorders such as lymphoma and chronic lymphocytic leukemia. She has helped establish the haplo-identical (half-matched donor) transplant program at  RUMC and has lead the use of donor lymphocyte infusion as a modality to treat post-transplant relapse. Her active research endeavors are focused on the use of transplantation in the management of lymphoma and evaluation of the use of novel targeted agents in the post-transplant setting.  Dr. Nathan is fluent in English, Hindi, Malayalam and Marathi and is conversant in Swedish. ​ 



​​​Rush's transplant program is fully accredited for:

  • Allogeneic and autologous marrow 
  • Peripheral blood progenitor cell transplantation, including cell collection and laboratory processing

For more information on BMT, click here

Accreditation and Recognition

Rush University Cancer Center
1725 W. Harrison St.
Professional Building I
Suite 1010
Chicago, IL 60612
Phone: (312) 942-5904
Fax: (312) 942-3192
Driving Directions

Rush Cancer Care in Lisle
430 Warrenville Road
Suite 200
Lisle, IL 60532
Phone: (630) 724-8700
Fax: (630) 724-8702
Driving Directions

Practice Resources

Forgot MyChart Username? Forgot Password?
Additional Practice Information